Risk factors for weight gain following switch to integrase inhibitor–based antiretroviral therapy

JE Lake, K Wu, SH Bares, P Debroy… - Clinical Infectious …, 2020 - academic.oup.com
Background Treatment initiation with integrase strand transfer inhibitors (INSTIs) has been
associated with excess weight gain. Whether similar gains are seen after switch to INSTIs …
被引用次数：169 相关文章

Risk Factors for Weight Gain following Switch to Integrase Inhibitor-Based Antiretroviral Therapy

JE Lake, K Wu, SH Bares, P Debroy… - Clinical Infectious …, 2020 - scholars.northwestern.edu
Background: Treatment initiation with integrase strand transfer inhibitors (INSTIs) has been
associated with excess weight gain. Whether similar gains are seen after switch to INSTIs …

Risk factors for weight gain following switch to integrase inhibitor-based antiretroviral therapy.

JE Lake, K Wu, SH Bares, P Debroy, C Godfrey… - 2020 - cabidigitallibrary.org
Background: Treatment initiation with integrase strand transfer inhibitors (INSTIs) has been
associated with excess weight gain. Whether similar gains are seen after switch to INSTIs …
[HTML] nih.gov

[HTML][HTML] Risk Factors for Weight Gain Following Switch to Integrase Inhibitor–Based Antiretroviral Therapy

JE Lake, K Wu, SH Bares, P Debroy… - … Diseases: An Official …, 2020 - ncbi.nlm.nih.gov
Background Treatment initiation with integrase strand transfer inhibitors (INSTIs) has been
associated with excess weight gain. Whether similar gains are seen after switch to INSTIs …

Risk Factors for Weight Gain Following Switch to Integrase Inhibitor-Based Antiretroviral Therapy.

JE Lake, K Wu, SH Bares, P Debroy… - … Diseases: an Official …, 2020 - europepmc.org
Background Treatment initiation with integrase strand transfer inhibitors (INSTIs) has been
associated with excess weight gain. Whether similar gains are seen after switch to INSTIs …

Risk Factors for Weight Gain following Switch to Integrase Inhibitor-Based Antiretroviral Therapy

JE Lake, K Wu, SH Bares, P Debroy… - Clinical Infectious …, 2020 - experts.nebraska.edu
Background: Treatment initiation with integrase strand transfer inhibitors (INSTIs) has been
associated with excess weight gain. Whether similar gains are seen after switch to INSTIs …

Risk Factors for Weight Gain Following Switch to Integrase Inhibitor–Based Antiretroviral Therapy

JE Lake, K Wu, SH Bares, P Debroy… - Clinical Infectious …, 2020 - academic.oup.com
Background Treatment initiation with integrase strand transfer inhibitors (INSTIs) has been
associated with excess weight gain. Whether similar gains are seen after switch to INSTIs …

Risk Factors for Weight Gain Following Switch to Integrase Inhibitor-Based Antiretroviral Therapy

JE Lake, K Wu, SH Bares, P Debroy… - … publication of the …, 2020 - pubmed.ncbi.nlm.nih.gov
Background Treatment initiation with integrase strand transfer inhibitors (INSTIs) has been
associated with excess weight gain. Whether similar gains are seen after switch to INSTIs …

Risk Factors for Weight Gain Following Switch to Integrase Inhibitor–Based Antiretroviral Therapy.

JE Lake, K Wu, SH Bares, P Debroy… - Clinical Infectious …, 2020 - search.ebscohost.com
Background Treatment initiation with integrase strand transfer inhibitors (INSTIs) has been
associated with excess weight gain. Whether similar gains are seen after switch to INSTIs …